Bath & Body Works, Inc. (NYSE:BBWI) Shares Bought by Impax Asset Management Group plc

Impax Asset Management Group plc grew its position in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 305.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 356,910 shares of the company's stock after purchasing an additional 268,913 shares during the period. Impax Asset Management Group plc owned approximately 0.16% of Bath & Body Works worth $15,404,000 at the end of the most recent quarter.

Several other institutional investors have also recently modified their holdings of the company. Front Row Advisors LLC acquired a new position in Bath & Body Works during the third quarter valued at $25,000. Trust Co. of Vermont acquired a new position in shares of Bath & Body Works in the 3rd quarter valued at about $27,000. Denali Advisors LLC acquired a new position in shares of Bath & Body Works in the 4th quarter valued at about $27,000. Money Concepts Capital Corp boosted its stake in shares of Bath & Body Works by 1,180.4% in the fourth quarter. Money Concepts Capital Corp now owns 653 shares of the company's stock worth $28,000 after buying an additional 602 shares during the last quarter. Finally, Turtle Creek Wealth Advisors LLC acquired a new stake in Bath & Body Works during the fourth quarter worth about $35,000. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Trading Down 1.7 %

BBWI traded down $0.77 on Wednesday, hitting $45.37. 1,903,927 shares of the company's stock were exchanged, compared to its average volume of 2,814,412. Bath & Body Works, Inc. has a fifty-two week low of $27.30 and a fifty-two week high of $50.34. The stock has a market cap of $10.20 billion, a price-to-earnings ratio of 11.98, a P/E/G ratio of 1.52 and a beta of 1.86. The firm has a 50-day moving average price of $46.01 and a 200-day moving average price of $39.53.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings results on Thursday, February 29th. The company reported $2.06 earnings per share for the quarter, topping analysts' consensus estimates of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The firm had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same period in the previous year, the business posted $1.86 earnings per share. Bath & Body Works's quarterly revenue was up .8% on a year-over-year basis. On average, equities analysts predict that Bath & Body Works, Inc. will post 3.3 EPS for the current year.

Bath & Body Works Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were given a dividend of $0.20 per share. The ex-dividend date was Thursday, February 22nd. This represents a $0.80 annualized dividend and a dividend yield of 1.76%. Bath & Body Works's payout ratio is 20.78%.

Wall Street Analysts Forecast Growth

Several equities research analysts have commented on BBWI shares. Telsey Advisory Group restated an "outperform" rating and issued a $53.00 price objective on shares of Bath & Body Works in a research report on Friday, April 5th. Piper Sandler increased their price target on shares of Bath & Body Works from $44.00 to $45.00 and gave the stock a "neutral" rating in a report on Tuesday. BMO Capital Markets lifted their price objective on shares of Bath & Body Works from $48.00 to $50.00 and gave the company an "outperform" rating in a report on Friday, March 1st. The Goldman Sachs Group increased their target price on shares of Bath & Body Works from $49.00 to $56.00 and gave the stock a "buy" rating in a research note on Monday, March 4th. Finally, Barclays lowered Bath & Body Works from an "overweight" rating to an "equal weight" rating and lifted their price target for the company from $37.00 to $45.00 in a research note on Thursday, January 4th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of "Hold" and a consensus target price of $46.33.

Insider Activity at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of Bath & Body Works stock in a transaction that occurred on Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total transaction of $209,493.65. Following the sale, the insider now owns 45,992 shares of the company's stock, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 0.19% of the stock is currently owned by insiders.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.